Therefore, our study reinforces the utilisation of exenatide as a GLP-1 analogue in the management of T2DM and additionally emphasises the efficacious properties of this GLP-1 analogue with regard to improvements in both weight and glycaemic control. The gene discussed is GCG; the disease is type 2 diabetes mellitus.